Predicting the Development of Diabetes in Older Adults
The derivation and validation of a prediction rule
- Alka M. Kanaya, MD1,
- Christina L. Wassel Fyr, MS1,
- Nathalie de Rekeneire, PHD2,
- Ronald I. Shorr, MD3,
- Ann V. Schwartz, PHD1,
- Bret H. Goodpaster, PHD4,
- Anne B. Newman, MD, MPH4,
- Tamara Harris, MD2 and
- Elizabeth Barrett-Connor, MD5
- 1Department of Medicine and Epidemiology and Biostatics, University of California, San Francisco, California
- 2National Institute on Aging, National Institutes of Health, Bethesda, Maryland
- 3Department of Preventive Medicine, University of Tennessee, Memphis, Tennessee
- 4Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania
- 5Department of Family and Preventive Medicine, University of California, San Diego, California
- Address correspondence and reprint requests to Alka M. Kanaya, MD, 1635 Divisadero St., Suite 600, San Francisco, CA 94115. E-mail: alkak{at}itsa.ucsf.edu
Abstract
OBJECTIVE— To create a simple prediction rule that could perform as well as the 2-h postchallenge plasma glucose (PCPG) test to predict those at risk for diabetes. We created a prediction rule in one sample and prospectively validated it for incident diabetes in a separate cohort.
RESEARCH DESIGN AND METHODS— A cross-sectional analysis with data from the Rancho Bernardo Study (age 67 ± 11 years) to derive a rule predicting abnormal PCPG ≥140 mg/dl, using demographic, clinical, and laboratory data of nondiabetic participants with fasting plasma glucose (FPG) <126 mg/dl. Data from the Health, Aging and Body Composition study (age 74 ± 3 years) were used to prospectively validate this rule for incident diabetes and compare it with the predictive ability of the PCPG test.
RESULTS— Of 1,549 RBS participants, 514 (33%) had PCPG ≥140 mg/dl. Female sex, age, triglycerides, and FPG were most significantly associated with abnormal PCPG. Based on standardized β-coefficients, we allotted 1 point for female sex, triglycerides ≥150 mg/dl, or FPG 95–104 mg/dl. Age ≥70 years or FPG 105–115 mg/dl were given 2 points, and FPG 116–125 mg/dl received 3 points. In the validation cohort, this simple prediction rule was as good as the 2-h PCPG test for predicting incident diabetes (C-statistic: 0.71 for both).
CONCLUSIONS— Advanced age, female sex, FPG, and triglycerides were able to predict adults at risk for diabetes equally well as the 2-h PCPG test. Using this rule, clinicians may better identify older persons who should receive intensive lifestyle intervention to prevent type 2 diabetes.
- FPG, fasting plasma glucose
- Health ABC, Health, Aging and Body Composition
- IFG, impaired fasting glucose
- IGT, impaired glucose tolerance
- PCPG, postchallenge plasma glucose
- RBS, Rancho Bernardo Study
- ROC, receiver operating characteristic
Footnotes
-
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
-
- Accepted October 27, 2004.
- Received June 22, 2004.
- DIABETES CARE














